Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma
Tuesday, August 03, 2021Alkermes plc announced that the US Food and Drug Administration FDA has granted Fast Track designation to nemvaleukin alfa nemvaleukin the companys novel investigational engineered interleukin IL variant immunotherapy for the treatment of mucosal mel...
DisperSol and Catalent Collaborate to Establish KinetiSol® Technology Manufacturing Hub for DisperSol Pharmaceutical Pipeline
Tuesday, August 03, 2021DisperSol Technologies a clinicalstage pharmaceutical company developing new treatments for oncology and rare diseases and Catalent the leading global provider of advanced delivery technologies development and manufacturing solutions for drugs biolog...
GC Pharma and Tottori University Enter Research Collaboration and License Agreement for Development of GM1 Gangliosidosis Chaperone Therapy
Monday, August 02, 2021GC Pharma and Tottori University today announced a worldwide licensing and collaboration agreement for the orally administrable chaperone drug of GM gangliosidosis GM GM is one of the inherited lysosomal storage diseases caused by mutations in the GL...
Melior Pharmaceuticals Announces Execution of License Agreement for Armesocarb by Adhera Therapeutics
Friday, July 30, 2021Melior Pharmaceuticals Melior announced that it completed a definitive licensing agreement with Adhera Therapeutics Inc for Meliors Parkinsons disease PD candidate MLR armesocarb As with all of Meliors drug candidates MLR is a repositioned drug that...
Shuttle Pharma Awarded a New Patent for Selective Inhibitors for Cancer Treatment
Friday, July 30, 2021Shuttle Pharmaceuticals Holdings Inc a Marylandbased developer of new drugs for cancer treatment was awarded US Patent No B for Selective Histone Deacetylase Inhibitors for the treatment of Human Disease These noncytotoxic highly selective inhibitor...
Bluebird Bio and Resilience Announce Strategic Alliance to Develop Next Generation Cell Therapies
Thursday, July 29, 2021National Resilience Inc and bluebird bio Inc today announced a strategic alliance aimed to accelerate the early research development and delivery of cell therapies As part of the agreement Resilience will acquire bluebirds Research Triangle bRT manuf...
GSK and Vir Biotechnology Announce Joint Procurement Agreement with European Commission for COVID-19 Treatment, Sotrovimab
Thursday, July 29, 2021GlaxoSmithKline plc and Vir Biotechnology Inc today announced they have signed a Joint Procurement Agreement with the European Commission to supply up to doses of sotrovimab an investigational single dose SARSCoV monoclonal antibody for the treatmen...
Cyclo Therapeutics Commences Commercial-Scale Manufacturing for Trappsol® Cyclo™
Wednesday, July 28, 2021Cyclo Therapeutics Inc a clinical stage biotechnology company dedicated to developing lifechanging medicines through science and innovation for patients and families living with diseases today announced that it has commenced the commercialscale produ...
Harrow Health Acquires Patented Ophthalmic Surgical Drug Candidate from Sintetica
Wednesday, July 28, 2021Harrow Health Inc an ophthalmicfocused healthcare company today announced that it has entered into an agreement with Sintetica SA a growing pharmaceutical company focused on analgesics local anesthetics and sterile injectable solutions to acquire the...
Biogen and Ionis report positive topline clinical data on investigational Alzheimer's disease treatment at AAIC
Tuesday, July 27, 2021Biogen Inc and Ionis Pharmaceuticals Inc announced that topline data from a Phase b placebocontrolled multiple ascending dose clinical study showed that BIIBIONISMAPTRx met its primary objective of safety and tolerability in patients with mild Alzhei...
